Zilebesiran, a Small Interfering RNA Therapeutic Targeting Angiotensinogen: Mechanism, Clinical Evidence, Safety, and Implementation Considerations.

Jawaria, Noor A, Zarlashat Y, Khan MEA, Loureiro EM, Dósa E

Open source

DOI
10.3390/life16081301
Published
2026 Aug 8
Container
Life (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/life16081301,
  title = {Zilebesiran, a Small Interfering RNA Therapeutic Targeting Angiotensinogen: Mechanism, Clinical Evidence, Safety, and Implementation Considerations.},
  author = {Jawaria and Noor A and Zarlashat Y and Khan MEA and Loureiro EM and Dósa E},
  year = {2026},
  journal = {Life (Basel, Switzerland)},
  doi = {10.3390/life16081301},
  url = {https://doi.org/10.3390/life16081301}
}

RIS

TY  - JOUR
TI  - Zilebesiran, a Small Interfering RNA Therapeutic Targeting Angiotensinogen: Mechanism, Clinical Evidence, Safety, and Implementation Considerations.
AU  - Jawaria
AU  - Noor A
AU  - Zarlashat Y
AU  - Khan MEA
AU  - Loureiro EM
AU  - Dósa E
PY  - 2026
JO  - Life (Basel, Switzerland)
DO  - 10.3390/life16081301
UR  - https://doi.org/10.3390/life16081301
ER  - 

APA

Jawaria, A, N., Y, Z., MEA, K., EM, L., & E, D. (2026). Zilebesiran, a Small Interfering RNA Therapeutic Targeting Angiotensinogen: Mechanism, Clinical Evidence, Safety, and Implementation Considerations.. Life (Basel, Switzerland). https://doi.org/10.3390/life16081301

Source records